Given the known associations between lipoprotein particle composition, inflammatory markers, and CHD, we hypothesized that advanced lipid parameters, including HDL subfractions, small dense LDL-C, and key inflammatory biomarkers such as MPO and SAA, provide superior risk stratification for CHD compared with standard lipid metrics. Here, MPO is linked to coronary artery disorder.